Responses
Regular and young investigator award abstracts
Clinical trials in progress
382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study
Compose a Response to This Article
Other responses
No responses have been published for this article.
